Chih‐Cheng Lai

19.4k total citations · 2 hit papers
444 papers, 12.0k citations indexed

About

Chih‐Cheng Lai is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chih‐Cheng Lai has authored 444 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Epidemiology, 156 papers in Infectious Diseases and 91 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chih‐Cheng Lai's work include Antibiotic Resistance in Bacteria (56 papers), COVID-19 Clinical Research Studies (49 papers) and Respiratory Support and Mechanisms (40 papers). Chih‐Cheng Lai is often cited by papers focused on Antibiotic Resistance in Bacteria (56 papers), COVID-19 Clinical Research Studies (49 papers) and Respiratory Support and Mechanisms (40 papers). Chih‐Cheng Lai collaborates with scholars based in Taiwan, China and United States. Chih‐Cheng Lai's co-authors include Po‐Ren Hsueh, Wen‐Chien Ko, Hung-Jen Tang, Chien‐Ming Chao, Yu‐Tsung Huang, Hung-Jen Tang, Chun‐Hsing Liao, Cheng‐Yi Wang, Ping‐Ing Lee and Ya‐Hui Wang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chih‐Cheng Lai

421 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

2020 4.1k citations Chih‐Cheng Lai, Wen‐Chien Ko et al. International Journal of Antimicrobial Agents profile →
Increased antimicrobial resistance during the COVID-19 pandemic

2021 290 citations Chih‐Cheng Lai, Wen‐Chien Ko et al. International Journal of Antimicrobial Agents profile →

Peers

Countries citing papers authored by Chih‐Cheng Lai

Since Specialization

Citations

This map shows the geographic impact of Chih‐Cheng Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Cheng Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Cheng Lai more than expected).

Fields of papers citing papers by Chih‐Cheng Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Cheng Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Cheng Lai. The network helps show where Chih‐Cheng Lai may publish in the future.

Co-authorship network of co-authors of Chih‐Cheng Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Cheng Lai. A scholar is included among the top collaborators of Chih‐Cheng Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Cheng Lai. Chih‐Cheng Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness and Safety of High-Dose versus Standard-Dose Cefoperazone-Sulbactam in Severe Infections: A Multicenter Retrospective Study 2025 ·Infection and Drug Resistance ·(unknown), Chi‐Kuei Hsu, Chih‐Cheng Lai, (unknown), Hung-Jen Tang, Kuang‐Ming Liao, (unknown), (unknown), Yu‐Hsin Chiu, (unknown)	0
2	A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD 2025 ·Nature Communications ·Jheng‐Yan Wu, Wan‐Hsuan Hsu, (unknown), Ya‐Wen Tsai, (unknown), Po‐Yu Huang, Min‐Hsiang Chuang, (unknown), Tsung Yu, Chih‐Cheng Lai	2
3	Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A five-year retrospective cohort analysis of 160,752 patients 2025 ·Diabetes Research and Clinical Practice ·(unknown), (unknown), Tsung Yu, Jheng‐Yan Wu, Chih‐Cheng Lai	1
4	Clinical Impact of Tirzepatide on Patients With OSA and Obesity 2025 ·CHEST Journal ·(unknown), Chia‐Chen Chen, (unknown), Wan‐Hsuan Hsu, (unknown), Ya‐Wen Tsai, Po‐Yu Huang, Min‐Hsiang Chuang, Kuo‐Chuan Hung, Tsung Yu, Chih‐Cheng Lai	2
5	High ceftazidime-avibactam resistance among carbapenem-resistant Enterobacter species: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–2021 2024 ·International Journal of Antimicrobial Agents ·Jiun‐Ling Wang, Chih‐Cheng Lai, Ya‐Wen Tsai, Wen‐Chien Ko, Po‐Ren Hsueh	3
6	Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime/avibactam: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014–21 2024 ·International Journal of Antimicrobial Agents ·Jiun‐Ling Wang, Chih‐Cheng Lai, Ya‐Wen Tsai, (unknown), Wen‐Chien Ko, Po‐Ren Hsueh	3
7	Post-pandemic epidemiological trends of respiratory infectious diseases in Taiwan: A retrospective analysis 2024 ·Journal of Microbiology Immunology and Infection ·(unknown), Ya‐Wen Tsai, Chih‐Cheng Lai, Hung-Jen Tang	2
8	Economic benefit analysis of the application of eco-friendly aquaculture technology in the farming of groupers and the fourfinger threadfin 2024 ·Journal of Environmental Management ·Ann‐Chang Cheng, (unknown), Chih‐Cheng Lai, Yishan Li, Yikai Luo, (unknown)	3
9	Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19 2023 ·International Journal of Antimicrobial Agents ·Jheng‐Yan Wu, Mei‐Yuan Liu, (unknown), Min‐Hsiang Chuang, Wan‐Hsuan Hsu, Po‐Yu Huang, Ya‐Wen Tsai, Chih‐Cheng Lai	9
10	Global trends in non-susceptibility rates of Streptococcus pneumoniae isolates to ceftriaxone: Data from the antimicrobial testing leadership and surveillance (ATLAS) programme, 2016–21 2023 ·International Journal of Antimicrobial Agents ·Jiun‐Ling Wang, Chih‐Cheng Lai, Wen‐Chien Ko, Po‐Ren Hsueh	3
11	Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized control trials 2023 ·Journal of Medical Virology ·Po‐Yu Huang, Tinghui Liu, Jheng‐Yan Wu, Ya‐Wen Tsai, Chih‐Cheng Lai	10
12	Effectiveness of oral antiviral agents on long‐term cardiovascular risk in nonhospitalized patients with COVID‐19: A multicenter matched cohort study 2023 ·Journal of Medical Virology ·Tinghui Liu, Min‐Hsiang Chuang, Jheng‐Yan Wu, Po‐Yu Huang, Ya‐Wen Tsai, Wan‐Hsuan Hsu, Chih‐Cheng Lai	11
13	The effect of nirmatrelvir‐ritonavir on the long‐term risk of neuropsychiatric sequelae following COVID‐19 2023 ·Journal of Medical Virology ·Tinghui Liu, Jheng‐Yan Wu, Po‐Yu Huang, Ya‐Wen Tsai, Chih‐Cheng Lai	9
14	Emergence and dissemination of multidrug-resistant Escherichia coli ST8346 coharboring blaNDM-5 and blaOXA-181 in Southern Taiwan, 2017–2021 2023 ·Journal of Infection and Public Health ·(unknown), Nan–Yao Lee, Chien‐Ming Chao, Chi‐Chung Chen, Chih‐Cheng Lai, Chung‐Han Ho, Yu-Chin Chen, Po‐Yu Chen, Hung-Jen Tang, Hung-Jui Chen, (unknown), (unknown), Julie Chi Chow, Tu‐Hsuan Chang	4
15	Antimicrobial Susceptibility of E. coli Isolates from Intra-Abdominal Infections in the Asia-Pacific Region: Trends in Ciprofloxacin, Ceftriaxone, Cefepime, and Piperacillin/Tazobactam Susceptibility 2023 ·Infection and Drug Resistance ·(unknown), Yu-Chin Chen, Po‐Yu Chen, Chih‐Cheng Lai, Hung-Jen Tang, Yin-Ching Chuang, Chi‐Chung Chen, Chung‐Han Ho, Wei-Yun Hsu, Tu‐Hsuan Chang	2
16	Effect of COVID-19 on the Long-term Cardiovascular Outcomes among Patients with Alcohol Use Disorder: A Retrospective Cohort Study Including 45,842 Patients 2023 ·Journal of Addiction Medicine ·(unknown), Jheng‐Yan Wu, Po‐Yu Huang, Ya‐Wen Tsai, Chih‐Cheng Lai	0
17	Long COVID: An inevitable sequela of SARS-CoV-2 infection 2022 ·Journal of Microbiology Immunology and Infection ·Chih‐Cheng Lai, Chi‐Kuei Hsu, Muh‐Yong Yen, Ping‐Ing Lee, Wen‐Chien Ko, Po‐Ren Hsueh	84
18	Effectiveness of early rehabilitation on patients with chronic obstructive lung disease and acute respiratory failure in intensive care units: A case–control study 2019 ·Chronic Respiratory Disease ·Willy Chou, Chih‐Cheng Lai, Kuo-Chen Cheng, Kuo‐Shu Yuan, (unknown), (unknown)	6
19	Infections caused by Gordonia species at a medical centre in Taiwan, 1997 to 2008 2010 ·Clinical Microbiology and Infection ·Chih‐Cheng Lai, (unknown), (unknown), Chee‐Kiat Tan, (unknown), Chun‐Hsing Liao, Chien‐Hong Chou, Yu‐Tsung Huang, H.I. Lin, Po‐Ren Hsueh	41
20	Infections Caused byGordoniaSpecies at a Medical Center in Taiwan, 1997 to 2008 2009 ·Clinical Microbiology and Infection ·Chih‐Cheng Lai, (unknown), (unknown), Chee‐Kiat Tan, Sheng‐Hsiang Lin, Chun‐Hsing Liao, Chien‐Hong Chou, Yu‐Tsung Huang, H.I. Lin, Po‐Ren Hsueh	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact